DANIEL P. SCHUSTER, M.D.; GARY R. ZUCKERMAN, D.O.
To the editor: The findings recently reported by Puera and Johnson (1) may superficially appear to contradict data previously presented by us (2). Significant differences in the patient population under scrutiny are an important factor in this regard. We believe these differences should be emphasized to interpret properly the conclusions of each study.
In our study, a complete accounting of all patients admitted to the intensive care unit was reported. The risk of "bleeding" (defined as guaiac positivity in nasogastric aspirate or stool specimens) was 14% in the group as a whole, but 48% in patients admitted for more than
SCHUSTER DP, ZUCKERMAN GR. Cimetidine in Intensive Care Units. Ann Intern Med. ;103:959–960. doi: 10.7326/0003-4819-103-6-959_2
Download citation file:
Published: Ann Intern Med. 1985;103(6_Part_1):959-960.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use